Grace Therapeutics, Inc. Common Stock Shares Outstanding

Quick Answer

Grace Therapeutics, Inc. reported Common Stock Shares Outstanding of 9.40 million shares for the year ending 2024.

  • Grace Therapeutics, Inc. showed an increase of +26.4% in Common Stock Shares Outstanding from 2023 to 2024.
  • This data is from Grace Therapeutics, Inc.'s annual report (Form 10-K), filed with the SEC on June 21, 2024.
  • XBRL data for this metric is available from 2022 to 2024 (3 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 3 years of available data (2022 to 2024), Grace Therapeutics, Inc.'s Common Stock Shares Outstanding has declined by 78.8%.
  • Historical annual values: Fiscal year 2024: 9.40 million shares | Fiscal year 2023: 7.44 million shares | Fiscal year 2022: 44.29 million shares.
  • Data sourced from SEC EDGAR public filings as of June 22, 2026.

Last verified: